Vitamin B3 Fights Brain Cancer, Saputo Bets on Whey

A striking vitamin B3 trial and Saputo's new whey ingredients division are reshaping how health brands think about niacin, protein supply, and differentiation. Here's what marketers need to know today. In this episode: A small clinical trial found high-dose vitamin B3 (niacin) kept 82% of glioblastoma patients alive when used alongside standard treatment, giving supplement brands a credible — if carefully navigable — new science story for thought leadership content. A meta-analysis of 16 clinical trials found omega-3 supplementation produced modest but real cognitive performance gains in children with ADHD, giving children's nutrition brands a more targeted, evidence-backed angle than broad 'brain health' claims. New research found that specific mulberry compounds can remodel the gut microbiome and support metabolic function, with synergistic effects from compound combinations signalling a differentiation opportunity for early-mover gut health brands in Europe. Canadian dairy giant Saputo has created a standalone ingredients division focused on whey protein, a structural supply-side shift that could affect pricing and ingredient availability for sports nutrition and functional food brands over the medium term. The Health Marketing Daily is a concise briefing for marketers and founders in supplements, functional food and consumer health, hosted by Marco & Klara. New episode every day. Enjoying the show? A quick rating or review on Apple Podcasts or Spotify helps other marketers find us. Also from Marco & Klara: The FMCG Marketing Daily · The Digital Commerce Daily